NIH: Office of Disease Prevention

Medicine: Mind the Gap

Helping Smokers With Behavioral Health Comorbidity Requires a National Effort

Jill Marie Williams, M.D.
Professor of Psychiatry and

Division of Addiction Psychiatry
University of Medicine and Dentistry of New Jersey
Robert Wood Johnson Medical School

Tuesday, April 16, 2013
Building 45 (Natcher), Balcony C
NIH Campus | Bethesda, Maryland


Cosponsored by

U.S. Department of Health and Human Services
Working Group on Tobacco Control and
Behavioral Health

About the Seminar

Dr. Williams will be speaking about the fact that although public health interventions have led to lower smoking rates in the United States over the last 40 years, smokers with mental illness or an addiction other than smoking have benefited less from these efforts. At this time, little is being done nationally at the mental health or public health systems level to promote smoking cessation in this population. Moreover, she will talk about how little is known about smokers with mental illness or an addictive behavior because of the lack of critical information on their tobacco use patterns and trends, as well as on the effects of tobacco control measures such as excise taxes, advertising, or clean indoor air laws on this population. Dr. Williams will discuss how smokers with behavioral health comorbidity are not listed as a disparity group or priority population by most national public health or tobacco control groups, although they fulfill the criteria commonly used to designate other groups (e.g., targeted marketing by the tobacco industry, greater smoking prevalence rates, increased economic and health burden from tobacco, less access to treatment services, and longer durations of smoking with less cessation). Designating them a priority group will bring much needed attention and resources. The disparity between smoking rates in the behavioral health population compared with the general population will worsen over time if their needs remain unaddressed.

About Jill M. Williams, M.D.

Dr. Williams is Professor of Psychiatry and Director of the Division of Addiction Psychiatry at the University of Medicine and Dentistry of New Jersey (UMDNJ)-Robert Wood Johnson Medical School in New Brunswick. She also holds faculty appointments at the Cancer Institute of New Jersey and is affiliated with the UMDNJ-Tobacco Dependence Program and Rutgers Center for Alcohol Studies. She received her medical degree from UMDNJ-Robert Wood Johnson Medical School in Piscataway and completed her residency training at Duke University Medical Center in Durham, North Carolina. Dr. Williams also completed a fellowship in addiction psychiatry at UMDNJ-Robert Wood Johnson Medical School.

The focus of Dr. Williams’s work has been in addressing tobacco in individuals with mental illness. She is a member of the Association for the Treatment of Tobacco Use and Dependence, the American Psychiatric Association, the Society for Research on Nicotine and Tobacco, and the American Association of Community Psychiatrists. The CHOICES Program (Consumers Helping Others Improve Their Condition by Ending Smoking), which she cofounded, has won numerous awards for innovative programming. Dr. Williams has developed training curricula for behavioral health professionals and manualized treatments for treating tobacco in mental health settings.

Dr. Williams has received research funding from sources including the National Institute on Drug Abuse, National Institute of Mental Health, and American Legacy Foundation. Her publications have appeared in numerous journals including Nicotine and Tobacco Research, the Journal of the American Medical Association, andthe Journal of Substance Abuse Treatment.

Previous Webinars

Stepped Wedge Cluster Randomized Designs for Disease Prevention Research
Presented by Monica Taljaard, Ph.D.
July 11, 2018
Sizing Up Systematic Reviews: Not All Syntheses Are Created Equal
Presented by Jennifer Croswell, M.D., M.P.H.
June 7, 2018
Study Design and Analysis Methods for Examining the Implementation and Impact of Obesity and Tobacco-Related Law and Policy on Practices, Community Environments, and Individual Behaviors/Attitudes
Presented by Jamie Chriqui, Ph.D., M.H.S.
May 22, 2018
Design and Analysis of Individually Randomized Group-Treatment Trials in Public Health
Presented by Sherri Pals, Ph.D.
April 24, 2018
Using Networks to Link Genotype to Phenotype
Presented by John Quackenbush, Ph.D.
March 5, 2018
Measurement of Physical Activity in Children and Adolescents
Presented by Russell R. Pate, Ph.D.
January 17, 2018
Research Methods Resources for Clinical Trials Involving Groups or Clusters
Presented by David M. Murray, Ph.D.
December 13, 2017
Automating Machine Learning for Prevention Research
Presented by Jason Moore, Ph.D.
August 29, 2017
Use of the Electronic Medical Record in Prevention Research
Presented by William M. Vollmer, Ph.D.
June 15, 2017
Dissemination and Implementation Research: Challenges and Opportunities
Presented by Maria E. Fernandez, Ph.D.
April 20, 2017
Mixed Methods in Disease Prevention and Health Promotion Research
Presented by Leonard A. Jason, Ph.D.
March 27, 2017
Engaging in Qualitative Research Methods: Opportunities for Prevention and Health Promotion
Presented by LeConté J. Dill, Dr.P.H., M.P.H.
January 19, 2017
Series Topic #3: Overdiagnosis in Cancer Screening: Overcoming Challenges, Avoiding Mistakes
Presented by Ruth B. Etzioni, Ph.D.
November 18, 2016
Series Topic #2: Guidelines for Screening in Children
Presented by David C. Grossman, M.D., M.P.H.
October 20, 2016
Series Topic #1: Making Guidelines for Colon Cancer Screening: Evidence, Policy, and Politics
Presented by David F. Ransohoff, M.D.
September 27, 2016
The Opportunities and Challenges of Using Systematic Reviews To Summarize Knowledge About "What Works" in Disease Prevention and Health Promotion
Presented by Kay Dickersin, Ph.D.
July 25, 2016
More Webinars